Proteostasis Management is the systemic clinical strategy focused on maintaining the integrity, synthesis, folding, trafficking, and degradation of the entire proteome—all the proteins within a cell or organism. This management is essential for cellular health, as misfolded or aggregated proteins are a primary driver of aging and neurodegenerative disease. Optimizing proteostasis is a key longevity mechanism that directly impacts the function of hormone receptors and signaling molecules.
Origin
This term is derived from molecular biology and cell biology, combining ‘proteo’ (protein) and ‘stasis’ (stability/homeostasis). It is a concept that recognizes the dynamic, highly regulated system required to maintain protein quality control. Clinical strategies for management emerged from research into aging and the pathology of protein-misfolding diseases.
Mechanism
Management protocols enhance the activity of cellular quality control pathways, including the ubiquitin-proteasome system and autophagy. Targeted interventions, such as specific amino acid profiles or pharmacological chaperones, can improve protein folding and prevent aggregation. By ensuring the proper structure and function of all proteins, including enzymes and hormone receptors, proteostasis management directly supports the fidelity of endocrine signaling and overall cellular resilience.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.